z-logo
open-access-imgOpen Access
l-Aminoacyl-triazine Derivatives Are Isoform-Selective PI3Kβ Inhibitors That Target Nonconserved Asp862 of PI3Kβ
Author(s) -
JoAnne Pinson,
Zhihai Zheng,
Michelle S. Miller,
David K. Chalmers,
Ian G. Jennings,
Phillip E. Thompson
Publication year - 2012
Publication title -
acs medicinal chemistry letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.065
H-Index - 66
ISSN - 1948-5875
DOI - 10.1021/ml300336j
Subject(s) - gene isoform , pi3k/akt/mtor pathway , chemistry , pharmacology , medicine , biochemistry , signal transduction , gene
A series of aminoacyl-triazine derivatives based upon the pan-PI3K inhibitor ZSTK474 were identified as potent and isoform selective inhibitors of PI3Kβ. The compounds showed selectivity based upon stereochemistry with L-amino acyl derivatives preferring PI3Kβ while their D-congeners favoured PI3Kδ. The mechanistic basis of this inhibition was studied using site-directed mutants. One Asp residue, D862 was identified as a critical participant in binding to the PI3Kβ-selective inhibitors distinguishing this class from other reported PI3Kβ-selective inhibitors. The compounds show strong inhibition of cellular Akt phosphorylation and growth of PTEN-deficient MD-MBA-468 cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here